Growth Metrics

Merck (MRK) Gross Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 531.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -168.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 449.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 134.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -367.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 129.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -1,698.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -714.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 134.00
Dec 31, 2025 -579.00
Sep 30, 2025 398.00
Jun 30, 2025 639.00
Mar 31, 2025 1,182.00
Dec 31, 2024 415.00
Sep 30, 2024 173.00
Jun 30, 2024 398.00
Mar 31, 2024 766.00
Dec 31, 2023 1,920.00
Sep 30, 2023 86.00
Jun 30, 2023 261.00
Mar 31, 2023 37.00
Dec 31, 2022 985.00
Sep 30, 2022 589.00
Jun 30, 2022 3.00
Mar 31, 2022 -562.00
Dec 31, 2021 125.00
Sep 30, 2021 730.00
Jun 30, 2021 543.00
Mar 31, 2021 162.00
Dec 31, 2020 -1,296.00
Sep 30, 2020 446.00
Jun 30, 2020 201.00
Mar 31, 2020 485.00
Dec 31, 2019 -360.00
Sep 30, 2019 17.00
Jun 30, 2019 743.00
Mar 31, 2019 1,014.00
Dec 31, 2018 778.00
Sep 30, 2018 381.00
Jun 30, 2018 571.00
Mar 31, 2018 614.00
Dec 31, 2017 279.00
Sep 30, 2017 797.00
Jun 30, 2017 1,337.00
Mar 31, 2017 571.00
Dec 31, 2016 638.00
Sep 30, 2016 485.00
Jun 30, 2016 256.00
Mar 31, 2016 -126.00
Dec 31, 2015 -225.00
Sep 30, 2015 -133.00
Jun 30, 2015 -496.00
Mar 31, 2015 -345.00
Dec 31, 2014 -180.00
Sep 30, 2014 -380.00
Jun 30, 2014 -949.00
Mar 31, 2014 -297.00
Dec 31, 2013 -399.00
Sep 30, 2013 47.00
Jun 30, 2013 118.00
Mar 31, 2013 857.00
Dec 31, 2012 1,311.00
Sep 30, 2012 -1,237.00
Jun 30, 2012 -1,045.00
Mar 31, 2012 -965.00